Search Results for "Peginesatide Wikipedia"
Matching Channels
Biosimilars - news, reports, views and blogs
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusi...
A tumor or tumour is the name for a neoplasm or a solid lesion formed by an abnormal growth of cells (termed neoplastic) which looks like a swelling. Tumor is not synonymous with cancer. A tumor can...
Diagnostics - news, views, blogs
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease...
Bioethics - news, views and reports
Bioethics is the study of controversial ethics brought about by advances in biology and medicine. Bioethicists are concerned with the ethical questions that arise in the relationships among life sci...
Cloning in biology is the process of producing similar populations of genetically identical individuals that occurs in nature when organisms such as bacteria, insects or plants reproduce asexually....
Matching News
Wikipedia needs pharma; pharma needs Wikipedia
The chances are your children use Wikipedia more than you do. Nowadays scholars are directed to Wikipedia for research and… Read more
Informal awards contribute to higher Wikipedia participation
When researchers decided to find out what makes Wikipedia work, they knew they faced quite a challenge. After all, neither monetary compensation nor formal work relations explain the success of this a...
Anaemia: The safety and efficacy of peginesatide in patients with CKD
Recently published data from four phase 3 safety and efficacy trials show that the synthetic peptide-based, erythropoietin mimetic, peginesatide, is noninferior to conventional erythropoiesis-stimulat...
Peginesatide Recall and Fatal Anaphylaxis: A Perspective
Jeffrey Berns comments on the recall of peginesatide, the recently approved erythropoiesis-stimulating agent, in light of deaths from a severe allergic reaction in dialysis patients. Medscape Nephro...
Takeda, Affymax sign supply agreement for Omontys (peginesatide) injection
Takeda Pharmaceuticals USA (TPUSA) and Affymax have announced supply agreement with US Renal Care for Omontys (peginesatide) injection in the US.
Peginesatide safe for anemia in patients undergoing dialysis
(HealthDay)—Peginesatide, a peptide-based erythropoiesis-stimulating agent, is safe and effective in patients with advanced chronic kidney disease and anemia as long as they are undergoing dialysis,...
Anonymous Editing on Wikipedia Keeps Morgellons Sufferers in the Dark
Austin, TX (PRWEB) May 08, 2013 A series of important new studies provide evidence that Morgellons disease has an infectious origin which should be treatable. Yet, despite this good news, thousands...
Affymax jumps on peginesatide supply deal with Fresenius
Affymax Inc. (NASDAQ:AFFY) jumped $2.29 (19%) to $14.24 on Thursday after the biotech and partner Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) announced a supply agreement for Omontys peginesatide with...
Matching PubMed Articles
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.
Peginesatide is a peptide-based erythropoiesis-stimulating agent (ESA) that may have therapeutic potential for anemia in patients with advanced chronic kidney disease. We evaluated the safety and effi...
BACKGROUND: Although mental health information on the internet is often of poor quality, relatively little is known about the quality of websites, such as Wikipedia, that involve participatory informa...
The pharmacokinetics (PK) (absorption, distribution, metabolism, excretion) of peginesatide, a synthetic, PEGylated, investigational, peptide-based erythropoiesis-stimulating agent (ESA), was evaluate...
Peginesatide in patients with anemia undergoing hemodialysis.
Peginesatide, a synthetic peptide-based erythropoiesis-stimulating agent (ESA), is a potential therapy for anemia in patients with advanced chronic kidney disease.
Peginesatide as a new approach for treating anemia of CKD patient: is it like a falling star?
Any scientific innovation needs to translate into a significant benefit. Peginesatide is noninferior to other erythropoiesis stimulating agents (ESAs) in terms of efficacy, and it shares the advantage...
